Children's Cancer Group, China
Clinical trials sponsored by Children's Cancer Group, China, explained in plain language.
-
New hope for kids with rare cancer: modified chemo shows promise
Disease control OngoingThis study tests a modified chemotherapy regimen (ALCL99) in 172 Chinese children and teens with newly diagnosed high-risk anaplastic large cell lymphoma. The goal is to see if the modified treatment improves 3-year survival without the cancer coming back, compared to past result…
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New chemo combo aims to boost survival in kids with rare lymphoma
Disease control OngoingThis study tests a modified chemotherapy regimen for Chinese children and teens newly diagnosed with lymphoblastic lymphoma. The goal is to improve survival rates compared to previous treatments. About 150 participants will receive the adjusted therapy, and researchers will track…
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Can a U.S.-Proven strategy boost survival for chinese kids with rare hodgkin lymphoma?
Disease control OngoingThis study tests whether a treatment plan that works well in the U.S. can also help Chinese children and teens with newly diagnosed Hodgkin lymphoma. About 200 participants aged 1 to 18 will receive the modified therapy, and researchers will track how long they stay cancer-free a…
Phase: PHASE4 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC